News

Seductive Reasoning,” a flop that preceded the Roches’ debut, has a fluctuating sonic palette, contributions from Paul Simon ...
The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its ...
Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is ...
The big pharma joined several of its peers in committing to invest billions of dollars in new and expanded manufacturing ...
Repertoire Immune Medicines will get $35 million upfront, and possibly $730 million more, in a deal to help Roche’s Genentech ...
The investment would go toward high-tech research and development sites and new manufacturing facilities in Indiana, ...
Roche’s Genentech has inked a deal with Repertoire Immune Medicines aimed at discovering and developing T-cell-targeted ...
Roche projected that its $50 billion manufacturing investment, to include R&D operations, will generate 1,000 jobs at the ...
The commitment will include new, state-of-the-art R&D facilities as well as new or expanded manufacturing sites in multiple ...
Roche’s Genentech is betting on the Flagship Pioneering–founded company’s discovery platform called DECODE to find new ...
Roche has picked up a CE Mark approval in the EU for an artificial intelligence algorithm that can help doctors decide whether patients presenting with acute chest pain are having a heart attack.
In the latest episode of 1923, the Yellowstone prequel created by Taylor Sheridan, several characters meet their end, including one of the most notorious figures in the series.